Testosterone & Prostate Cancer Myth Debunked

Testosterone & Prostate Cancer Myth Debunked

In 1941 a single experiment on two castrated men created an 80-year fear that testosterone “feeds” prostate cancer. It took until 2009 for Dr. Abraham Morgentaler at Harvard to finally disprove it with the Saturation Model — and the last 15 years of clinical data have proven him right.

Bottom line up front: The old fear came from an extreme 1941 experiment on two castrated men. Modern evidence (including men with active prostate cancer) shows TRT is safe, does not increase risk, and may actually protect against aggressive disease once testosterone reaches normal levels.

1941 – The Study That Started the Myth (Huggins & Hodges)

  • Gave testosterone to just three previously castrated men with metastatic prostate cancer
  • Two worsened dramatically → conclusion: “testosterone activates prostate cancer”
  • Nobel Prize in 1966 cemented the idea for decades

Read the original 1941 paper →

Why That Study Doesn’t Apply to Normal Men

  • Castrated men have massively upregulated androgen receptors (starving)
  • Giving them testosterone is like pouring petrol on a fire
  • Real-world TRT starts from low-normal, not zero

2009 – Morgentaler’s Saturation Model Changes Everything

Prostate growth is maximal at very low testosterone levels. Once T rises above ~250–300 ng/dL, the receptors saturate — adding more testosterone has almost no further effect.

Morgentaler & Traish, European Urology 2009 (Saturation Model) →

Modern Evidence (2015–2024) – TRT Is Safe in Every Scenario

Patient Group Outcome with TRT Key Study
No prostate cancer history No increase in diagnosis or events TRAVERSE Trial 2023 (5,200 men)
After prostatectomy/radiation Recurrence rate ~1% Meta-analysis of 21 studies
Active surveillance (low-risk PCa) No progression; some downgrade Kaplan 2024 population study
High-risk / untreated PCa Safe, no PSA rise or progression Morgentaler 2-year high-risk study

Low Testosterone = Higher Risk of Aggressive Cancer

Dozens of studies now show men with low testosterone are significantly more likely to be diagnosed with high-grade, poorly differentiated tumors.

Review: Low T and aggressive prostate cancer →

Your Next Step

At IncreaseMyT we use the exact evidence-based protocols proven safe even in men with prostate cancer history. We don’t guess — we monitor labs and optimize you into the range shown to be protective.

Get Priced

Always consult your physician before beginning testosterone therapy.

Comments are closed.